Search Results - "PAPPO, Alberto"
-
1
Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas
Published in Journal of clinical oncology (10-01-2018)“…Several recent advances have been made in the diagnosis and therapy of malignant small round cell tumors that affect children, particularly in…”
Get full text
Journal Article -
2
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
Published in The lancet oncology (01-05-2018)“…Gene fusions involving NTRK1, NTRK2, or NTRK3 (TRK fusions) are found in a broad range of paediatric and adult malignancies. Larotrectinib, a highly selective…”
Get full text
Journal Article -
3
Germline Mutations in Predisposition Genes in Pediatric Cancer
Published in The New England journal of medicine (10-12-2015)“…A constitutive mutation in a cancer-susceptibility gene can have implications for clinical treatment and genetic counseling of family members. This study…”
Get full text
Journal Article -
4
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
Published in The lancet oncology (01-04-2020)“…The selective TRK inhibitor larotrectinib was approved for paediatric and adult patients with advanced TRK fusion-positive solid tumours based on a primary…”
Get full text
Journal Article -
5
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study
Published in The lancet oncology (01-01-2020)“…Tumour grade, tumour size, resection potential, and extent of disease affect outcome in paediatric non-rhabdomyosarcoma soft-tissue sarcoma (NRSTS), but no…”
Get full text
Journal Article -
6
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas
Published in Cancer (01-11-2018)“…Background The highly selective oral tropomyosin receptor kinase (TRK) inhibitor larotrectinib has demonstrated significant activity in adult and pediatric TRK…”
Get full text
Journal Article -
7
Top advances of the year: Pediatric oncology
Published in Cancer (01-10-2022)“…Accelerated discovery and collaborative research continue to highlight the remarkable progress that has been made in the diagnosis and treatment of pediatric…”
Get full text
Journal Article -
8
Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study
Published in Journal of clinical oncology (10-12-2019)“…The treatment of childhood nasopharyngeal carcinoma has been adapted from adult regimens; pediatric-specific studies are limited. The ARAR0331 study sought to…”
Get full text
Journal Article -
9
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
Published in Clinical cancer research (01-11-2017)“…Anti-GD2 mAbs, acting via antibody-dependent cell-mediated cytotoxicity, may enhance the effects of chemotherapy. This pilot trial investigated a fixed dose of…”
Get full text
Journal Article -
10
Recent advances in understanding and managing pediatric rhabdomyosarcoma [version 1; peer review: awaiting peer review]
Published in F1000 research (2020)“…Rhabdomyosarcoma (RMS) is a high-grade malignant neoplasm, with a morphologic appearance mimicking that of developing skeletal muscle. Over the last 30 years,…”
Get full text
Journal Article -
11
Feasibility of indocyanine green‐guided localization of pulmonary nodules in children with solid tumors
Published in Pediatric blood & cancer (01-10-2023)“…Background Clearing all pulmonary metastases is essential for curing pediatric solid tumors. However, intraoperative localization of such pulmonary nodules can…”
Get full text
Journal Article -
12
R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
Published in Journal of clinical oncology (01-12-2011)“…The type 1 insulin-like growth factor 1 receptor (IGF-1R) has been implicated in the pathogenesis of the Ewing sarcoma family of tumors (ESFT). We conducted a…”
Get full text
Journal Article -
13
A prospective, comprehensive registry that integrates the molecular analysis of pediatric and adolescent melanocytic lesions
Published in Cancer (15-10-2021)“…Background Childhood melanocytic tumors represent a diagnostic and therapeutic challenge, and additional research is needed to better define the natural…”
Get full text
Journal Article -
14
Optimal dosing of cyclophosphamide in rhabdomyosarcoma: It's complicated
Published in Cancer (15-09-2019)“…Cyclophosphamide dosing has previously been implicated as a risk factor for local failure in rhabdomyosarcoma. Casey et al report on findings from ARST0531…”
Get full text
Journal Article -
15
Analysis of Prognostic Factors in Patients With Nonmetastatic Rhabdomyosarcoma Treated on Intergroup Rhabdomyosarcoma Studies III and IV: The Children's Oncology Group
Published in Journal of clinical oncology (20-08-2006)“…The outcome for localized rhabdomyosarcoma (RMS) or undifferentiated sarcoma (UDS) is affected by age, histology, primary anatomic site, extent of disease, and…”
Get full text
Journal Article -
16
Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma
Published in Cell reports (Cambridge) (01-04-2014)“…Pediatric osteosarcoma is characterized by multiple somatic chromosomal lesions, including structural variations (SVs) and copy number alterations (CNAs). To…”
Get full text
Journal Article -
17
Germline genomic findings in children and young adults with melanocytic tumors
Published in Pediatric blood & cancer (01-07-2023)“…In this retrospective study, we examined the prevalence and spectrum of germline variants in selected cancer predisposition genes in 38 children and young…”
Get full text
Journal Article -
18
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic
Published in JAMA oncology (01-07-2016)“…Wild-type (WT) gastrointestinal stromal tumors (GISTs), which lack KIT and PDGFRA gene mutations, are the primary form of GIST in children and occasionally…”
Get more information
Journal Article -
19
Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol
Published in Journal of clinical oncology (01-08-2021)“…Adrenocortical carcinoma (ACC) is a rare aggressive pediatric malignancy with distinct biology. Its treatment follows the principles developed for adults;…”
Get full text
Journal Article -
20
Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic
Published in Journal of clinical oncology (10-02-2017)“…Purpose Wild-type gastrointestinal stromal tumors (WT-GISTs) that lack KIT or PDGFRA mutations represent a unique subtype of GIST that predominantly affects…”
Get full text
Journal Article